I get what your saying. I've been surprised at the dates I see on stories...2018...2015 ....
So I get it. But I have a feeling we are hitting a new phase just now. I liked the Missling quote someone posted here (yesterday? years ago?!) where he said something to the effect that "When this is over, you'll look back and what I've done will make sense." I know tat's easy to say (and perhaps a bit egomaniacal!) but I think I see evidence that that will be the case. And gathering evidence is what it was all about. And I think they've gathered enough now. I think it was about discovering in what "patient" or just human "situations" does kicking in or kicking up the Sigma1 thing cause a real benefit for certain people and situations.
I'm thinking that Alzheimer's is a huge population and our function there might only have meaning for a slice - but that's okay. Parkinson's maybe a bit bigger slice. But I'm thinking the other conditions that are not age-related will be where we might really provide a benefit to maybe all of those populations. Like Rett maybe. But I'm thinking depression, maybe autism, schizophrenia, anxiety, insomnia. We'll see. AD and PD are headline makers and possibly that's why we started there.
I think I'm done and will just sit back and see how it goes. But I'm "confident" our drug will help someone somehow someday.
